MTOR and prostate cancer: This corroborates other studies that suggest Tan IIA may inhibit PI3K/Akt/mTOR signaling in gastric carcinoma and prostate cancer models51,52, and serves as a validation for the efficacy and accuracy of our chemogenomics-based strategy.